Literature DB >> 21093502

Modulation of neurotransmitter receptors and synaptic differentiation by proteins containing complement-related domains.

Minoru Nakayama1, Chihiro Hama.   

Abstract

Neurotransmitter receptors play central roles in basic neurotransmission and synaptic plasticity. Recent studies have revealed that some transmembrane and extracellular proteins bind to neurotransmitter receptors, forming protein complexes that are required for proper synaptic localization or gating of core receptor molecules. Consequently, the components of these complexes contribute to long-term potentiation, a process that is critical for learning and memory. Here, we review factors that regulate neurotransmitter receptors, with a focus on proteins containing CUB (complement C1r/C1s, Uegf, Bmp1) or CCP (complement control protein) domains, which are frequently found in complement system proteins. Proteins that contain these domains are structurally distinct from TARPs (transmembrane AMPA receptor regulatory proteins), and may constitute new protein families that modulate either the localization or function of neurotransmitter receptors. In addition, other CCP domain-containing proteins participate in dendritic patterning and/or synaptic differentiation, although current evidence has not identified any direct activities on neurotransmitter receptors. Some of these proteins are involved in pathologic conditions such as epileptic seizure and mental retardation. Together, these lines of information have shown that CUB and CCP domain-containing proteins contribute to a wide variety of neuronal events that ultimately establish neural circuits.
Copyright © 2010 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093502     DOI: 10.1016/j.neures.2010.11.006

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  7 in total

1.  Proteolytic processing of the extracellular scaffolding protein LEV-9 is required for clustering acetylcholine receptors.

Authors:  Luis Briseño-Roa; Jean-Louis Bessereau
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

2.  The Matrix Proteins Hasp and Hig Exhibit Segregated Distribution within Synaptic Clefts and Play Distinct Roles in Synaptogenesis.

Authors:  Minoru Nakayama; Emiko Suzuki; Shin-ichi Tsunoda; Chihiro Hama
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

3.  Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3.

Authors:  Martina Pigoni; Hung-En Hsia; Jana Hartmann; Jasenka Rudan Njavro; Merav D Shmueli; Stephan A Müller; Gökhan Güner; Johanna Tüshaus; Peer-Hendrik Kuhn; Rohit Kumar; Pan Gao; Mai Ly Tran; Bulat Ramazanov; Birgit Blank; Agnes L Hipgrave Ederveen; Julia Von Blume; Christophe Mulle; Jenny M Gunnersen; Manfred Wuhrer; Gerhard Rammes; Marc Aurel Busche; Thomas Koeglsperger; Stefan F Lichtenthaler
Journal:  EMBO J       Date:  2020-06-22       Impact factor: 11.598

4.  Sez6 levels are elevated in cerebrospinal fluid of patients with inflammatory pain-associated conditions.

Authors:  Maria Roitman; Laura E Edgington-Mitchell; Jon Mangum; James Ziogas; Alexios A Adamides; Paul Myles; Hearan Choo-Bunnett; Nigel W Bunnett; Jenny M Gunnersen
Journal:  Pain Rep       Date:  2019-03-25

5.  The Sez6 Family Inhibits Complement by Facilitating Factor I Cleavage of C3b and Accelerating the Decay of C3 Convertases.

Authors:  Wen Q Qiu; Shaopeiwen Luo; Stefanie A Ma; Priyanka Saminathan; Herman Li; Jenny M Gunnersen; Harris A Gelbard; Jennetta W Hammond
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

6.  CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients.

Authors:  Nan Lu; Jinhui Liu; Mengting Xu; Jianqiang Liang; Yichun Wang; Zhipeng Wu; Yan Xing; Feiyang Diao
Journal:  Int J Gen Med       Date:  2021-11-04

7.  Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma.

Authors:  Ziming Wang; Jiaming Lai; Lijian Liang; Xiaoyu Yin; Qian Wang; Quanyong Cheng; Chaoxu Zheng
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.